Skip to main content
. 2022 Aug 15;2(8):742–755. doi: 10.1038/s43587-022-00263-3

Extended Data Fig. 7. Additional Metrics and Clinical Codes.

Extended Data Fig. 7

a Correlation coefficient matrix of metrics from nuclei. b Contour distribution of aspect versus area of nuclei for individuals under 40. c Contour distribution of aspect versus area of nuclei for individuals over 60. d Volcano plot of conditions based on IR senescence residuals and p values (two-sided Fisher’s exact test). e Volcano plot of conditions based on RS senescence probability residuals and p values (two-sided Fisher’s exact test). f Volcano plot of conditions based on doxorubicin senescence probability residuals and p values (two-sided Fisher’s exact test). g Volcano plot of conditions based on ATV/r senescence probability residuals and p values (two-sided Fisher’s exact test). h Volcano plot of conditions based on antimycin-A senescence probability residuals and p values (two-sided Fisher’s exact test). i Volcano plot of conditions based on probability of unified senescence probability residuals and p values (two-sided Fisher’s exact test). j Volcano plot of conditions based on percent IR senescence residuals and p values (two-sided Fisher’s exact test). k Volcano plot of conditions based on percent RS senescence residuals and p values (two-sided Fisher’s exact test). l Volcano plot of conditions based on percent doxorubicin senescence residuals and p values (two-sided Fisher’s exact test). m Volcano plot of conditions based on percent ATV/r senescence residuals and p values (two-sided Fisher’s exact test). n Volcano plot of conditions based on percent antimycin-A senescence residuals and p values (two-sided Fisher’s exact test). o Volcano plot of conditions based on percent unified senescence residuals and p values (two-sided Fisher’s exact test).